Moreover, p5091 was reported to significantly modulate the phenotype and function of M2 (CD11b+F4/80+CD86−CD206+) macrophages, and combinational treatment of p5091 and Programmed Cell Death 1 (PD1) antibody exerted synergistic anti-tumor effect in lung cancer [98]. Here, PDCD1 is linked to lung carcinoma.